US FDA sees potential for GCP memorandum with India
This article was originally published in Scrip
Executive Summary
The US FDA expects to work closely with Indian regulatory authorities in the area of good clinical practice (GCP), even as it aims to strengthen a "trusted" regulator-to-regulator relationship in India.